Skip to main content
| News

Novartis and Roche are among the most innovative companies

24.02.2020

Novartis and Roche feature among the hundred most innovative companies worldwide. This is from the Derwent Top 100 Global Innovators 2020 report. Roche is the only pharmaceutical company worldwide that has appeared in the list nine times.

Basel with Roche and Messe towers (img: Adriano Biondo)

The consulting company Clarivate Analytics based in London and Philadelphia has analyzed a total of 14,000 companies worldwide for its report Derwent Top 100 Global Innovators 2020. It lists two companies from Basel as some of the most innovative firms in the world. The pharmaceutical company Novartis has featured in this list every year since 2015 and is now one of the hundred most innovative companies in the world for the sixth time running. Its local competitor Roche has had a continuous presence in the list since 2012, making it the only pharmaceutical company in the world to be one of the globally most innovative companies for the ninth time. The third Swiss company in the list is ABB, a technology firm from Zurich.

These three entries in the list make Switzerland one of the most innovative countries in the world. China and South Korea are also represented by three listings, Taiwan and Germany by four companies, and France by five. The USA is now at the top of the list, with 39 innovative companies, which is six more than the previous year. Japan is still doing well, but with seven fewer companies than last year, it takes second place with 32 firms.

The analysts from Clarivate Analytics not only use the number of patents granted to the companies but also their influence on other innovators and their presence in the various major global markets to support their assessment. They also point out that the importance of large companies is dwindling in the world of innovation. The thousand most innovative companies in the world in 2019 only possessed 18 percent of all patents. Six years before, this was 27 percent. At the same time, they say that it is becoming more and more difficult for up-and-coming companies to gain access into the exclusive circle of the most innovative companies. stk

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

South Korean pharma firms show interest in the Basel Area

Several South Korean firms from the life sciences industry, including three pharmaceutical multinationals, have visited the Basel Area on fact-finding...

Read More
Gamma Technologies acquires ProFEMAG portfolio
Advanced Manufacturing/AI, Basel Area Business & Innovation, ICT, Innovation, Invest

Gamma Technologies acquires ProFEMAG portfolio

The Basel-based firm ProFEMAG AG has sold its FEMAG software for electrical machine applications to Gamma Technologies. The company based...

Read More
Basel Area Business & Innovation, ICT, Innovation, Invest, Life Sciences / biotech

Databaum establishes headquarters in Basel

Databaum is establishing its headquarters in Basel and plans to grow from its location there. The startup provides the agricultural...

Read More
Clinerion launches patient information platform
Basel Area Business & Innovation, Digital Health, ICT, Innovation, Invest, Life Sciences / biotech

Clinerion launches patient information platform

Basel-based Clinerion is introducing its machine learning platform. It comprises a global network of hospitals and enables researchers to recognize...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

New innovation campus opens in the Basel Area

The Main Campus of the Switzerland Innovation Park Basel Area was officially opened on October 29. In his speech, Federal...

Read More
Sumitovant acquires all shares in Myovant
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Sumitovant acquires all shares in Myovant

Sumitovant is in the process of making Basel-based Myovant Sciences a wholly owned subsidiary by acquiring a 100 percent shareholding...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

VectivBio raises 125 million US dollars in stock sale

VectivBio has announced the closing of the subscription offer for 16,700,000 ordinary shares. The Basel-based biotechnology firm has generated gross...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

KetoSwiss secures capital increase of 4 million dollars

KetoSwiss has banked a total of 4 million US dollars from investors. The Basel-based startup develops products to alleviate neurological...

Read More
Basel Area Business & Innovation, Invest, Life Sciences / biotech

Escientia Switzerland becomes Primopus

The Indian company Deccan Fine Chemicals is acquiring Escientia Switzerland and renaming it as Primopus AG. The new owner announces...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Novartis investing 100 million Swiss francs in new biologics center

The pharmaceutical company Novartis is investing a sum of 100 million Swiss francs in a new competence center for biologics...

Read More
1 2 3 35

Do you have a question? We'd like to hear from you.